Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


02.07.2018

1 Adv Sci (Weinh)
1 Asia Pac J Clin Oncol
1 Cancer Discov
1 Cancer Med
1 Cell Oncol (Dordr)
1 Cell Physiol Biochem
1 Clin Cancer Res
1 Curr Oncol Rep
1 Curr Urol Rep
1 Diabetes Res Clin Pract
1 Drug Des Devel Ther
1 EBioMedicine
1 Eur J Pharm Biopharm
1 Eur J Surg Oncol
1 Eur Urol
1 Int J Radiat Oncol Biol Phys
1 J Agric Food Chem
1 J Cancer Res Clin Oncol
1 J Clin Lab Anal
1 J Int Med Res
1 JAMA Surg
1 Neoplasma
1 Onco Targets Ther
1 Oncogene
1 PLoS One
2 Rev Urol
1 Turk J Urol
5 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Sci (Weinh)

  1. GUO H, Li F, Xu W, Chen J, et al
    Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.
    Adv Sci (Weinh). 2018;5:1800004.
    PubMed     Text format     Abstract available


    Asia Pac J Clin Oncol

  2. MI Y, Zhao Y, Shi F, Zhang M, et al
    Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Asia Pac J Clin Oncol. 2018 Jun 22. doi: 10.1111/ajco.13024.
    PubMed     Text format     Abstract available


    Cancer Discov


  3. Erdafitinib Efficacious in Bladder Cancer.
    Cancer Discov. 2018 Jun 27. pii: 2159-8290.CD-NB2018.
    PubMed     Text format     Abstract available


    Cancer Med

  4. LIN N, Wu YP, Lin YZ, Tao X, et al
    Risk factors for upper tract urothelial recurrence following local excision of bladder cancer.
    Cancer Med. 2018 Jun 28. doi: 10.1002/cam4.1642.
    PubMed     Text format     Abstract available


    Cell Oncol (Dordr)

  5. DUDEK AM, Vermeulen SH, Kolev D, Grotenhuis AJ, et al
    Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Cell Oncol (Dordr). 2018 Jun 28. pii: 10.1007/s13402-018-0393.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  6. WANG J, Fang R, Wang L, Chen G, et al
    Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
    Cell Physiol Biochem. 2018;47:1565-1577.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. LELO A, Prip F, Harris BT, Solomon D, et al
    STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jun 28. pii: 1078-0432.CCR-17-3244.
    PubMed     Text format     Abstract available


    Curr Oncol Rep

  8. JOHNSON SB, Yu JB
    Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Curr Oncol Rep. 2018;20:66.
    PubMed     Text format     Abstract available


    Curr Urol Rep

  9. SALTZMAN AF, Cost NG
    Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.
    Curr Urol Rep. 2018;19:11.
    PubMed     Text format     Abstract available


    Diabetes Res Clin Pract

  10. DAVIDSON MB, Pan D
    Erratum to "An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis" [Diab. Res. Clin. Pract. 135 (2018) 102-110].
    Diabetes Res Clin Pract. 2018 Jun 20. pii: S0168-8227(18)30968.
    PubMed     Text format    


    Drug Des Devel Ther

  11. BOURN J, Cekanova M
    Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
    Drug Des Devel Ther. 2018;12:1727-1742.
    PubMed     Text format     Abstract available


    EBioMedicine

  12. YANG Z, Zhang R, Ge Y, Qin X, et al
    Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.
    EBioMedicine. 2018 Jun 22. pii: S2352-3964(18)30218.
    PubMed     Text format     Abstract available


    Eur J Pharm Biopharm

  13. APFELTHALER C, Skoll K, Ciola R, Gabor F, et al
    A Doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.
    Eur J Pharm Biopharm. 2018 Jun 27. pii: S0939-6411(18)30082.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  14. VOSKUILEN CS, Fransen van de Putte EE, Perez-Reggeti JI, van Werkhoven E, et al
    Prostate sparing cystectomy for bladder cancer: A two-center study.
    Eur J Surg Oncol. 2018 Jun 8. pii: S0748-7983(18)31115.
    PubMed     Text format     Abstract available


    Eur Urol

  15. THOENY HC, Bellin MF, Comperat EM, Thalmann GN, et al
    Vesical Imaging-Reporting and Data System (VI-RADS): Added Value for Management of Bladder Cancer Patients?
    Eur Urol. 2018 Jun 27. pii: S0302-2838(18)30442.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  16. TANAKA H, Yoshida S, Koga F, Toda K, et al
    Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 27. pii: S0360-3016(18)31021.
    PubMed     Text format     Abstract available


    J Agric Food Chem

  17. XIA Y, Yuan M, Li S, Thuan UT, et al
    Apigenin suppresses IL-1beta-induced expression of urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-small ka, CyrillicB signaling in human bladder cancer T24 cells.
    J Agric Food Chem. 2018 Jun 27. doi: 10.1021/acs.jafc.8b02351.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  18. RINALDETTI S, Wirtz R, Worst TS, Hartmann A, et al
    FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2018 Jun 29. pii: 10.1007/s00432-018-2694.
    PubMed     Text format     Abstract available


    J Clin Lab Anal

  19. BEN WAFI S, Kallel A, Ben Fradj MK, Sallemi A, et al
    Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.
    J Clin Lab Anal. 2018 Jun 29:e22610. doi: 10.1002/jcla.22610.
    PubMed     Text format     Abstract available


    J Int Med Res

  20. ZHOU X, Ji H, Zhang H, Xiong T, et al
    Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer - practice in a single centre.
    J Int Med Res. 2018 Jan 1:300060518782015. doi: 10.1177/0300060518782015.
    PubMed     Text format     Abstract available


    JAMA Surg

  21. WILLIAMS SB, Shan Y, Jazzar U, Mehta HB, et al
    Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    JAMA Surg. 2018 Jun 27. pii: 2685879. doi: 10.1001/jamasurg.2018.1680.
    PubMed     Text format     Abstract available


    Neoplasma

  22. FENG SQ, Zhang XY, Fan HT, Sun QJ, et al
    Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Neoplasma. 2018 Jun 26. doi: 10.4149/neo_2018_180125.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  23. LI J, Cheng Y, Liu G, Ji Z, et al
    The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis.
    Onco Targets Ther. 2018;11:3449-3459.
    PubMed     Text format     Abstract available


    Oncogene

  24. PENG M, Wang J, Zhang D, Jin H, et al
    PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
    Oncogene. 2018 Jun 21. pii: 10.1038/s41388-018-0374.
    PubMed     Text format     Abstract available


    PLoS One

  25. BECKFORD VERA DR, Smith CC, Bixby LM, Glatt DM, et al
    Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
    PLoS One. 2018;13:e0193832.
    PubMed     Text format     Abstract available


    Rev Urol

  26. BJURLIN MA
    Management of Recurrent Non-Muscle Invasive Bladder Cancer.
    Rev Urol. 2018;20:38-40.
    PubMed     Text format    

  27. VELAZQUEZ N
    Bladder Cancer Academy 2018 Selected Summaries.
    Rev Urol. 2018;20:31-37.
    PubMed     Text format    


    Turk J Urol

  28. ISLAMOGLU E, Anil H, Erol I, Tas S, et al
    Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient.
    Turk J Urol. 2018;44:311-315.
    PubMed     Text format     Abstract available


    World J Urol

  29. SORIA F, Droller MJ, Lotan Y, Gontero P, et al
    An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 21. pii: 10.1007/s00345-018-2380.
    PubMed     Text format     Abstract available

  30. GARCIA-PERDOMO HA, Montes-Cardona CE, Guacheta M, Castillo DF, et al
    Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.
    World J Urol. 2018 Jun 25. pii: 10.1007/s00345-018-2384.
    PubMed     Text format     Abstract available

  31. KRABBE LM, Margulis V, Schrader AJ, Shariat SF, et al
    Molecularly-driven precision medicine for advanced bladder cancer.
    World J Urol. 2018 Jun 8. pii: 10.1007/s00345-018-2354.
    PubMed     Text format     Abstract available

  32. RINGUETTE-GOULET C, Bolduc S, Pouliot F
    Modeling human bladder cancer.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2369.
    PubMed     Text format     Abstract available

  33. FLETCHER SA, Harmouch SS, Krimphove MJ, Cole AP, et al
    Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2371.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: